XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Common Stock
Preferred Stock
Preferred A Stock
Additional Paid-In- Capital
Accumulated Deficit
Total Stockholders’ Equity (Deficit) attributable to Agrify
Non- Controlling Interests
Total
Balance at Dec. 31, 2022 $ 1 $ 237,875 $ (247,148) $ (9,272) $ 231 $ (9,041)
Balance (in Shares) at Dec. 31, 2022 1,038,298          
Stock-based compensation 859 859 859
Issuance of Common Stock through an at the market offering, net of fees 1,545 1,545 1,545
Issuance of Common Stock through an at the market offering, net of fees (in Shares) 323,082          
Issuance of Common Stock to Pure Pressure    
Issuance of Common Stock to Pure Pressure (in Shares) 366          
Vesting of restricted stock units (in Shares) 17          
Proceeds from Employee Stock Purchase Plan Shares 25 25 25
Proceeds from Employee Stock Purchase Plan Shares (in Shares) 2,500          
Net income (loss) (10,327) (10,327) (10,327)
Balance at Mar. 31, 2023 $ 1 240,304 (257,475) (17,170) 231 (16,939)
Balance (in Shares) at Mar. 31, 2023 1,364,263          
Stock-based compensation 752 752 752
Issuance of held-back shares to Lab Society (in Shares) 499          
Exercise of prefunded warrants in private placement (in Shares) 35,000          
Conversion of Exchange Note 2,146 2,146 2,146
Conversion of Exchange Note (in Shares) 69,567          
Conversion of Convertible Note $ 1 1,171 1,172 1,172
Conversion of Convertible Note (in Shares) 153,617          
Net income (loss) (6,807) (6,807) 2 (6,805)
Balance at Jun. 30, 2023 $ 2 244,373 (264,282) (19,907) 233 (19,674)
Balance (in Shares) at Jun. 30, 2023 1,622,946          
Balance at Dec. 31, 2023 $ 2 250,855 (265,797) (14,940) 230 (14,710)
Balance (in Shares) at Dec. 31, 2023 1,701,243          
Stock-based compensation 490 490 490
Issuance of Common Stock and prefunded warrants through public offering $ 3 2,120 2,123 2,123
Issuance of Common Stock and prefunded warrants through public offering (in Shares) 2,760,000          
Issuance of held-back shares from Sinclair acquisition (in Shares) 588          
Cashless exercise of High Trail Warrants $ 3 $ (3)
Cashless exercise of High Trail Warrants (in Shares) 3,132,217          
Exercise of Prefunded Warrants issued through public offering (in Shares) 3,000 3,000 3,000
Exercise of Prefunded Warrants issued through public offering (in Shares) 3,010,000          
Conversion of Convertible Note $ 2 $ 1,729 $ 1,731 $ 1,731
Conversion of Convertible Note (in Shares) 2,671,633          
Contribution from troubled debt restructuring with related party 676 676 676
Stock split share adjustment (in Shares) 21          
Net income (loss) 4,236 4,236 4,236
Balance at Mar. 31, 2024 $ 13 255,867 (261,561) (5,681) 230 (5,451)
Balance (in Shares) at Mar. 31, 2024 13,275,702          
Balance at Dec. 31, 2023 $ 2 250,855 (265,797) (14,940) 230 (14,710)
Balance (in Shares) at Dec. 31, 2023 1,701,243          
Conversion of Convertible Note (in Shares) 2,644,632              
Balance at Jun. 30, 2024 $ 14 272,783 (264,533) 8,264 230 8,494
Balance (in Shares) at Jun. 30, 2024 14,230,004          
Balance at Mar. 31, 2024 $ 13 255,867 (261,561) (5,681) 230 (5,451)
Balance (in Shares) at Mar. 31, 2024 13,275,702          
Stock-based compensation $ 81 $ 81 $ 81
Exercise of Prefunded Warrants issued through public offering (in Shares) 1,000 1,000 1,000
Exercise of Prefunded Warrants issued through public offering (in Shares) 953,684          
Conversion of related party debt into prefunded warrants $ 10,044 $ 10,044 $ 10,044
Issuance of equity classified prefunded warrants 6,791 6,791 6,791
Issuance of vested RSUs, net of shares held back to offset tax (in Shares) 618          
Net income (loss) (2,972) (2,972) (2,972)
Balance at Jun. 30, 2024 $ 14 $ 272,783 $ (264,533) $ 8,264 $ 230 $ 8,494
Balance (in Shares) at Jun. 30, 2024 14,230,004